Search

everythinglearnresearchcommunity

for

Search:↓

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

Future research should focus on making bioengineered skin that completely restores all skin functions.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Animal research has greatly advanced dermatology.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

Histone modification is key in treating chronic inflammatory skin diseases.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

Human stem cells were turned into cells similar to those that help grow hair and showed potential for hair follicle formation.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Hair growth-related cells need the enzyme SCD1 to help maintain the area that supports hair growth.

A group has developed therapies that show promise for treating cancer and various other conditions.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Tiny particles from skin cells can help activate hair growth.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.